ANNOUNCEMENT MADE PURSUANT TO RULE 13.51B(2) OF THE LISTING RULES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.Solargiga Energy Holdings Limited阳光能源控股有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 757) ANNOUNCEMENT MADE PURSUANT TO RULE 13.51B(2) OF THE LISTING RULES This announcement is made by Solargiga Energy Holdings Limited (the “Company” together with its subsidiaries the “Group”) pursuant to Rule 13.51B(2) of the Rules Governing the Listing of Securities (the “Listing Rules”) on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) in relation to an update of information of Dr.Wong Wing Kuen Albert (“Dr. Wong”) an independent non-executive director of the Company under Rule 13.51(2)(l) of the Listing Rules.The board of directors (the “Board”) of the Company was notified by Dr. Wong that Dexin China Holdings Company Limited (“Dexin China”) an independent third party unrelated to the Group was ordered to be wound up by the High Court of the Hong Kong Special Administrative Region (the “High Court”) on 11 June 2024 (the “Winding-up Order”) and the Official Receiver was appointed as the provisional liquidator of Dexin China. Dr. Wong had been an independent non-executive director of Dexin China from 11 January 2019 up until 11 June 2024 when he resigned as independent non-executive director of Dexin China with immediate effect.Based on publicly available information Dexin China is a company incorporated in the Cayman Islands with limited liability and Dexin China and its subsidiaries are principally engaged in the property development and construction services property investment and hotel operations in the People’s Republic of China. The shares of Dexin China are listed on the Main Board of the Stock Exchange (stock code: 2019) and have been suspended from trading since 11 June 2024.– 1 –According to the announcements of Dexin China dated 21 March 2024 and 12 June 2024 the Winding-up Order resulted from a winding-up petition against Dexin China dated 20 March 2024 filed by China Construction Bank (Asia) Corporation Limited in the High Court in relation to the non-payment of the 9.95% senior notes due in December 2022 issued by Dexin China in the principal amount of US$350000000 and accrued interests.For further information regarding the Winding-up Order and the proceedings in relation thereto please refer to the respective announcements of Dexin China dated 21 March 2024 5 June 2024 and 12 June 2024 published on the website of the Stock Exchange. As the Winding-up Order was made against Dexin China within 12 months of Dr. Wong’s cessation to act as an independent non-executive director of Dexin China it constitutes an event required to be disclosed by the Company pursuant to Rules 13.51(2)(l) and 13.51B(2) of the Listing Rules.The Company has no further information on the Winding-up Order other than those set out above which is based on the information supplied by Dr. Wong and publicly available information.As the Winding-up Order did not involve the Group the Board is of the view that the aforesaid matter does not have any impact on the business and operations of the Group nor does it affect Dr. Wong’s ability to discharge his duties as an independent non-executive director the chairman of the audit committee and a member of both the remuneration committee and the nomination committee of the Company.This announcement is made by the Company to report the change of information in relation to Dr. Wong in compliance with the requirements under Rule 13.51B(2) of the Listing Rules. Dr. Wong has confirmed that save as disclosed in this announcement there are no other matters in relation to him which are required to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Listing Rules and he is not aware of any other matters that need to be brought to the attention of the Company and its shareholders.By order of the Board Solargiga Energy Holdings Limited Tan Wenhua Chairman Hong Kong 14 June 2024 As at the date of this announcement the executive Directors are Mr. Tan Wenhua (Chairman) Mr. Tan Xin and Mr. Wang Junze the non-executive Director is Mr. Hsu You Yuan and the independent non-executive Directors are Dr. Wong Wing Kuen Albert Ms. Chung Wai Hang and Ms. Tan Ying.–2–